Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/RELIEF-THERAPEUTICS-HOLDI-5527488/news/Relief-gibt-mit-seinem-Partner-NeuroRx-den-Einschlu-von-150-Patienten-in-die-Phase-2b-3-Studie-mit-31771841/?utm_source=whatsapp&utm_medium=social&utm_campaign=share